Dashboard
Manage Tickers

ILMNILLUMINA, INC.

Nasdaq illumina.com


$ 131.40 $ -2.38 (-1.78 %)    

Friday, 30-Aug-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 476.00 $ 5.61 (1.19 %)
DIA $ 416.44 $ 2.30 (0.56 %)
SPY $ 563.62 $ 5.33 (0.95 %)
TLT $ 96.60 $ -1.04 (-1.07 %)
GLD $ 231.30 $ -1.66 (-0.71 %)
$ 131.4
$ 131.40 x 100
$ 131.47 x 100
-- - --
$ 86.49 - $ 166.67
968,971
na
20.93B
$ 1.05
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-03-2024 03-31-2024 10-Q
3 02-16-2024 12-31-2023 10-K
4 11-09-2023 10-01-2023 10-Q
5 08-10-2023 07-02-2023 10-Q
6 05-05-2023 04-02-2023 10-Q
7 02-17-2023 01-01-2023 10-K
8 11-04-2022 10-02-2022 10-Q
9 08-11-2022 07-03-2022 10-Q
10 05-05-2022 04-03-2022 10-Q
11 02-18-2022 01-02-2022 10-K
12 11-04-2021 10-03-2021 10-Q
13 08-05-2021 07-04-2021 10-Q
14 04-28-2021 04-04-2021 10-Q
15 02-17-2021 01-03-2021 10-K
16 10-30-2020 09-27-2020 10-Q
17 08-07-2020 06-28-2020 10-Q
18 05-01-2020 03-29-2020 10-Q
19 02-11-2020 12-29-2019 10-K
20 10-25-2019 09-29-2019 10-Q
21 07-31-2019 06-30-2019 10-Q
22 04-26-2019 03-31-2019 10-Q
23 02-12-2019 12-30-2018 10-K
24 10-24-2018 09-30-2018 10-Q
25 07-31-2018 07-01-2018 10-Q
26 04-25-2018 04-01-2018 10-Q
27 02-13-2018 12-31-2017 10-K
28 10-25-2017 10-01-2017 10-Q
29 08-03-2017 07-02-2017 10-Q
30 05-05-2017 04-02-2017 10-Q
31 02-14-2017 01-01-2017 10-K
32 11-08-2016 10-02-2016 10-Q
33 08-02-2016 07-03-2016 10-Q
34 05-09-2016 04-03-2016 10-Q
35 03-02-2016 01-03-2016 10-K
36 11-02-2015 09-27-2015 10-Q
37 07-31-2015 06-28-2015 10-Q
38 05-01-2015 03-29-2015 10-Q
39 02-18-2015 12-28-2014 10-K
40 10-29-2014 09-28-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

heres-how-much-1000-invested-in-illumina-20-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Illumina...
08/28/2024 20:30:33

argus-research-upgrades-illumina-to-buy-announces-150-price-target
Argus Research Upgrades Illumina to Buy, A...
08/28/2024 13:31:51

Argus Research analyst Jasper Hellweg upgrades Illumina (NASDAQ:ILMN) from Hold to Buy and announces $150 price target.

fda-approves-illumina-cancer-biomarker-test-with-two-companion-diagnostics-to-rapidly-match-patients-to-targeted-therapies
FDA Approves Illumina Cancer Biomarker Tes...
08/27/2024 13:19:03

TruSight Oncology Comprehensive is the first US FDA-approved, distributable comprehensive genomic profiling IVD kit with pan-ca...

sp-500-nasdaq-100-extend-8-session-winning-streak-as-wall-street-jitters-go-poof-mondays-key-stock-movers
S&P 500, Nasdaq 100 Extend 8-Session Winni...
08/19/2024 20:54:37

Core News & Articles
This HP Analyst Is No Longer Bullish; Here...
08/19/2024 13:36:38

this-cisco-analyst-turns-bullish-here-are-top-5-upgrades-for-friday
This Cisco Analyst Turns Bullish; Here Are...
08/16/2024 12:42:52

alibaba-to-rally-around-11-here-are-10-top-analyst-forecasts-for-friday
Alibaba To Rally Around 11%? Here Are 10 T...
08/16/2024 11:51:24

daiwa-capital-upgrades-illumina-to-buy-raises-price-target-to-154
Daiwa Capital Upgrades Illumina to Buy, Ra...
08/16/2024 09:30:06

Daiwa Capital analyst Narumi Nakagiri upgrades Illumina (NASDAQ:ILMN) from Neutral to Buy and raises the price target from $...

scotiabank-maintains-sector-outperform-on-illumina-lowers-price-target-to-164
Scotiabank Maintains Sector Outperform on ...
08/15/2024 21:04:08

Scotiabank analyst Sung Ji Nam maintains Illumina (NASDAQ:ILMN) with a Sector Outperform and lowers the price target from $1...

1000-invested-in-this-stock-20-years-ago-would-be-worth-47000-today
$1000 Invested In This Stock 20 Years Ago ...
08/14/2024 20:01:11

td-cowen-upgrades-illumina-to-buy-raises-price-target-to-144
TD Cowen Upgrades Illumina to Buy, Raises ...
08/14/2024 17:09:17

TD Cowen analyst Dan Brennan upgrades Illumina (NASDAQ:ILMN) from Hold to Buy and raises the price target from $126 to $144.

rbc-capital-reiterates-outperform-on-illumina-maintains-242-price-target
RBC Capital Reiterates Outperform on Illum...
08/14/2024 15:43:39

RBC Capital analyst Conor McNamara reiterates Illumina (NASDAQ:ILMN) with a Outperform and maintains $242 price target.

this-starbucks-analyst-turns-bullish-here-are-top-5-upgrades-for-wednesday
This Starbucks Analyst Turns Bullish; Here...
08/14/2024 13:01:26

barclays-upgrades-illumina-to-equal-weight-announces-125-price-target
Barclays Upgrades Illumina to Equal-Weight...
08/14/2024 11:40:43

Barclays analyst Luke Sergott upgrades Illumina (NASDAQ:ILMN) from Underweight to Equal-Weight and announces $125 price target.

illumina-says-co--broad-institute-of-mit-and-harvard-announce-research-partnership-to-advance-single-cell-sequencing-expects-its-strategy-to-enable-company-to-accelerate-its-revenue-growth-to-high-single-digits-by-2027
Illumina Says Co & Broad Institute Of MIT ...
08/13/2024 15:04:57

- Investor Presentation

illumina-sees-at-least-10-total-eps-growth-over-next-3-years-unveils-strategy-aimed-at-8-9-sales-growth-by-2027
Illumina Sees At Least 10% Total EPS Growt...
08/13/2024 15:00:26

-- Company poised to accelerate revenue growth into high single digits over next three years, enabled by core genomics portfoli...

expert-outlook-illumina-through-the-eyes-of-13-analysts
Expert Outlook: Illumina Through The Eyes ...
08/13/2024 13:01:14

piper-sandler-maintains-overweight-on-illumina-lowers-price-target-to-195
Piper Sandler Maintains Overweight on Illu...
08/13/2024 11:18:07

Piper Sandler analyst David Westenberg maintains Illumina (NASDAQ:ILMN) with a Overweight and lowers the price target from $...

td-cowen-maintains-hold-on-illumina-raises-price-target-to-126
TD Cowen Maintains Hold on Illumina, Raise...
08/07/2024 21:14:57

TD Cowen analyst Dan Brennan maintains Illumina (NASDAQ:ILMN) with a Hold and raises the price target from $122 to $126.

citigroup-maintains-buy-on-illumina-raises-price-target-to-155
Citigroup Maintains Buy on Illumina, Raise...
08/07/2024 19:23:38

Citigroup analyst Patrick Donnelly maintains Illumina (NASDAQ:ILMN) with a Buy and raises the price target from $140 to $155.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION